More than two years after the onset of the pandemic, changes in COVID-related policies and postures — as well as accompanying cultural shifts in the workplace — continue to drive trends in the job market for radiologists.

A Silicon Valley AI shop has been OK’d by the FDA to market software that automatically flags suspected pulmonary embolisms (PEs) and immediately notifies physicians.

Researchers have demonstrated a deep learning model that can correct course for breast radiologists who otherwise may have erroneously deemed tissue dense in screening exams.

A review and update for the Centers for Medicare and Medicaid Services (CMS) Merit-based Incentive Payment System (MIPS) by in 2022 with Barbara Rubel and Claudia Murray with information they presented at this year's RBMA meeting.

The Food & Drug Administration has drafted guidelines to help U.S. healthcare better prepare for and respond to events associated with these situations.

A multidisciplinary panel convened by the ACR has developed a set of quality measures aimed at boosting rates of appropriate follow-up care for patients with noncritical but actionable incidental findings.

Iodinated contrast is most widely used in patients undergoing CT studies for, in descending order, abdominopelvic, chest, head/neck and brain indications.

Computer-aided detection boosted by AI has often proven superior to traditional CAD over the past decade, yet the “new way” has been slow to win broad adoption.